September 19, 2023 Sophia Vida
Breaking News

BioStem Technologies Initiates Nationwide Launch of AmnioWrap2™ with Venture Medical

Leading wound market solutions provider will lead BioStem’s commercialization of AmnioWrap2™ AmnioWrap2 is a versatile allograft solution for wound applications POMPANO BEACH, FLORIDA, September 19, 2023 – BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placenta-derived biologics for advanced wound care, has entered an agreement … Continue reading “BioStem Technologies Initiates Nationwide Launch of AmnioWrap2™ with Venture Medical”